Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2000
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2377320A1 Methods for modulating fxr receptor activity
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376970A1 Thermogenesis-associated genes and thermogenesis-associated proteins of plant
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376217A1 Novel formulations comprising lipid-regulating agents
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375797A1 Organosilyl compounds having nuclear hormone receptor modulating activity
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/20/2000EP1061073A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060739A1 Slimming cosmetic composition containing L-arginine or a derivative thereof
12/20/2000EP1060192A2 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/20/2000EP1060191A1 Derivatives of glp-1 analogs
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060164A1 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
12/20/2000EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
12/20/2000EP1059927A1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells
12/20/2000EP0788352B1 Treatment of animals
12/20/2000EP0753526B1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient
12/20/2000EP0751944B1 Thiazolidines and oxazolidines substituted by a pyridine ring and their use as hypoglycemic agents
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
12/20/2000CN1277555A Composition for improving mental capabilities in mammals
12/20/2000CN1277554A Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
12/20/2000CN1277197A Stable crystal salt of 5-methyl tetrahydrofolic acid
12/20/2000CN1277043A Intelligence growth promoting granule with vitamins, amino acids,Ca, P, Fe and Zn
12/20/2000CN1277040A Oxygen-making up and stamina-strenthening liquid
12/20/2000CN1277028A Production process of compound Meilingzhihua health food series
12/20/2000CN1277027A Silkworm excrement extracting process, extract and its use
12/20/2000CN1059674C Hypolipidemic benzothiazepines
12/20/2000CN1059673C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
12/20/2000CN1059580C Sikang yangsheng health-care tablet
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162805 Use of an NK-1 receptor antagonist and an SSRI for treating obesity
12/19/2000US6162790 Oligopeptides
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000074784A1 Combination for treating weight gain associated with antipsychotic use comprising an atypical antipsychotic and an h2 antagonist
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074736A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074710A2 Methods for treating diabetes
12/14/2000WO2000074702A1 Compositions for the treatment of the catabolic state of prolonged critical illness
12/14/2000WO2000074689A1 Unfermented gel fraction from psyllium seed husks
12/14/2000WO2000074684A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
12/14/2000WO2000074679A1 Substituted piperidines as melanocortin-4 receptor agonists
12/14/2000WO2000074675A1 Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000074500A1 Compositions containing creatine in suspension
12/14/2000WO2000063208B1 Substituted imidazoles, their preparation and use
12/14/2000WO2000057190A3 Prediction of diabetes impaired wound healing
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000047568A3 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
12/14/2000WO2000045770A3 Compressed lecithin preparations
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2377369A1 Substituted piperidines as melanocortin-4 receptor agonists
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375914A1 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375148A1 Compositions for the treatment of the catabolic state of prolonged critical illness
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/13/2000EP1059100A2 Combinations of CRF antagonists and renin-angiotensin system inhibitors
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP0724583B1 Pyridazino quinoline compounds
12/13/2000CN1276790A Carboxamidothiazole derivs., preparation, pharmaceutical composition contg. them
12/13/2000CN1276731A Insoluble insulin compositions
12/13/2000CN1276244A 口服水解蛋白液 Oral liquid protein hydrolyzate
12/13/2000CN1276219A Medicine for treating hyperlipemia
12/13/2000CN1276212A Functional oligose food
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1059433C Arylalkyl (thio) carboxamides, processes forpreparing them and pharmaceutial composition contg. them
12/12/2000US6160114 Useful for the treatment of atherosclerotic conditions and coronary heart disease
12/12/2000US6160007 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
12/12/2000US6159997 Treatment of arteriosclerosis and xanthoma
12/12/2000US6159996 Polycyclic thiazolidin-2-ylidene amines, process for their preparation, and their use as pharmaceuticals
12/12/2000US6159974 LDL receptor gene expression promoters
12/12/2000US6159943 Use of ribose to prevent cramping and soreness in muscles
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 1298